• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Split dose and MiraLAX-based purgatives to enhance bowel preparation quality becoming common recommendations in the US.分次服用和米拉拉克(MiraLAX)类泻药以提高肠道准备质量在美国已成常见推荐。
Therap Adv Gastroenterol. 2013 Jan;6(1):5-14. doi: 10.1177/1756283X12464100.
2
Nationwide variability of colonoscopy preparation instructions.结肠镜检查准备说明的全国变异性。
Dig Dis Sci. 2014 Aug;59(8):1726-32. doi: 10.1007/s10620-014-3262-8. Epub 2014 Jul 2.
3
Shortened surveillance intervals following suboptimal bowel preparation for colonoscopy: results of a national survey.结肠镜检查肠道准备不充分时缩短监测间隔:一项全国性调查的结果。
Int J Colorectal Dis. 2013 Jan;28(1):73-81. doi: 10.1007/s00384-012-1559-7. Epub 2012 Aug 12.
4
MiraLAX-Gatorade bowel prep versus GoLytely before screening colonoscopy: an endoscopic database study in a community hospital.米拉拉克-佳得乐肠道准备与聚乙二醇电解质溶液在筛查结肠镜检查前的比较:社区医院内镜数据库研究。
J Clin Gastroenterol. 2012 Nov-Dec;46(10):e96-e100. doi: 10.1097/MCG.0b013e3182617bfb.
5
Split-dosed MiraLAX/Gatorade is an effective, safe, and tolerable option for bowel preparation in low-risk patients: a randomized controlled study.Split-dosed MiraLAX/Gatorade 是一种有效、安全且耐受良好的低危患者肠道准备选择:一项随机对照研究。
Am J Gastroenterol. 2012 Jul;107(7):1036-42. doi: 10.1038/ajg.2012.115. Epub 2012 May 8.
6
Miralax with gatorade for bowel preparation: a meta-analysis of randomized controlled trials.聚乙二醇电解质散联合佳得乐用于肠道准备:一项随机对照试验的荟萃分析
Am J Gastroenterol. 2014 Oct;109(10):1566-74. doi: 10.1038/ajg.2014.238. Epub 2014 Aug 19.
7
Gastroenterologists' perceived barriers to optimal pre-colonoscopy bowel preparation: results of a national survey.胃肠病学家认为的结肠镜检查前肠道准备达到最佳效果的障碍:一项全国性调查结果
J Cancer Educ. 2012 Jun;27(3):526-32. doi: 10.1007/s13187-012-0364-x.
8
Quality bowel preparation for surveillance colonoscopy in patients with inflammatory bowel disease is a must.炎症性肠病患者进行监测结肠镜检查时,高质量的肠道准备是必不可少的。
Gastrointest Endosc Clin N Am. 2014 Jul;24(3):379-92. doi: 10.1016/j.giec.2014.03.004. Epub 2014 May 6.
9
Adherence to CRC Screening and Surveillance Guidelines when Using Split-Dose Bowel Preparation.使用分剂量肠道准备时对结直肠癌筛查和监测指南的依从性。
Gastroenterol Res Pract. 2018 Jul 2;2018:8237824. doi: 10.1155/2018/8237824. eCollection 2018.
10
Randomized Controlled Trial: Split-dose and Same-day Large Volume Bowel Preparation for Afternoon Colonoscopy Have Similar Quality of Preparation.随机对照试验:下午结肠镜检查的分剂量和同日大剂量肠道准备具有相似的准备质量。
J Clin Gastroenterol. 2019 Nov/Dec;53(10):724-730. doi: 10.1097/MCG.0000000000001213.

引用本文的文献

1
The importance of colonoscopy bowel preparation for the detection of colorectal lesions and colorectal cancer prevention.结肠镜检查肠道准备对于结直肠病变检测及预防结直肠癌的重要性。
Endosc Int Open. 2020 May;8(5):E673-E683. doi: 10.1055/a-1127-3144. Epub 2020 Apr 17.
2
Optimizing bowel preparation for colonoscopy: a guide to enhance quality of visualization.优化结肠镜检查的肠道准备:提高可视化质量指南
Ann Gastroenterol. 2016 Apr-Jun;29(2):137-46. doi: 10.20524/aog.2016.0005.
3
Bowel cleansing before colonoscopy: Balancing efficacy, safety, cost and patient tolerance.结肠镜检查前的肠道准备:平衡疗效、安全性、成本和患者耐受性。
World J Gastrointest Endosc. 2016 Jan 10;8(1):4-12. doi: 10.4253/wjge.v8.i1.4.

本文引用的文献

1
Gastroenterologists' perceived barriers to optimal pre-colonoscopy bowel preparation: results of a national survey.胃肠病学家认为的结肠镜检查前肠道准备达到最佳效果的障碍:一项全国性调查结果
J Cancer Educ. 2012 Jun;27(3):526-32. doi: 10.1007/s13187-012-0364-x.
2
MiraLAX vs. Golytely: is there a significant difference in the adenoma detection rate?米拉拉克 vs. 高力乐:腺瘤检出率有显著差异吗?
Aliment Pharmacol Ther. 2011 Oct;34(7):775-82. doi: 10.1111/j.1365-2036.2011.04795.x. Epub 2011 Aug 17.
3
Bowel preparation with split-dose polyethylene glycol before colonoscopy: a meta-analysis of randomized controlled trials.结肠镜检查前口服分次聚乙二醇肠道准备:一项随机对照试验的荟萃分析。
Gastrointest Endosc. 2011 Jun;73(6):1240-5. doi: 10.1016/j.gie.2011.02.007.
4
Current practice and perception of screening for medication adherence in inflammatory bowel disease.当前炎症性肠病药物治疗依从性筛查的实践现状和认知。
J Clin Gastroenterol. 2011 Nov-Dec;45(10):878-82. doi: 10.1097/MCG.0b013e3182192207.
5
Vaccinating the inflammatory bowel disease patient: deficiencies in gastroenterologists knowledge.为炎症性肠病患者接种疫苗:消化内科医生知识的不足。
Inflamm Bowel Dis. 2011 Dec;17(12):2536-40. doi: 10.1002/ibd.21667. Epub 2011 Apr 28.
6
The impact of suboptimal bowel preparation on adenoma miss rates and the factors associated with early repeat colonoscopy.肠道准备不充分对腺瘤检出率的影响及与早期重复结肠镜检查相关的因素。
Gastrointest Endosc. 2011 Jun;73(6):1207-14. doi: 10.1016/j.gie.2011.01.051. Epub 2011 Apr 8.
7
Impact of low-residue diet on bowel preparation for colonoscopy.低渣饮食对结肠镜检查肠道准备的影响。
Dis Colon Rectum. 2011 Jan;54(1):107-12. doi: 10.1007/DCR.0b013e3181fb1e52.
8
MiraLAX is not as effective as GoLytely in bowel cleansing before screening colonoscopies.米拉拉克在筛查结肠镜检查前的肠道清洁中不如加来他利有效。
Clin Gastroenterol Hepatol. 2011 Apr;9(4):326-332.e1. doi: 10.1016/j.cgh.2010.11.007. Epub 2010 Nov 27.
9
Randomised clinical trial: MiraLAX vs. Golytely - a controlled study of efficacy and patient tolerability in bowel preparation for colonoscopy.随机临床试验:米拉拉克 vs. 高力替利——结肠镜检查肠道准备中疗效和患者耐受性的对照研究。
Aliment Pharmacol Ther. 2011 Jan;33(1):33-40. doi: 10.1111/j.1365-2036.2010.04493.x. Epub 2010 Oct 25.
10
Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States.美国嗜酸粒细胞性胃肠道疾病的流行情况、诊断标准和初始治疗选择存在差异。
J Pediatr Gastroenterol Nutr. 2011 Mar;52(3):300-6. doi: 10.1097/MPG.0b013e3181eb5a9f.

分次服用和米拉拉克(MiraLAX)类泻药以提高肠道准备质量在美国已成常见推荐。

Split dose and MiraLAX-based purgatives to enhance bowel preparation quality becoming common recommendations in the US.

机构信息

Associate Research Scientist, Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 West 168th Street, New York, NY 10032, USA.

出版信息

Therap Adv Gastroenterol. 2013 Jan;6(1):5-14. doi: 10.1177/1756283X12464100.

DOI:10.1177/1756283X12464100
PMID:23320046
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3539296/
Abstract

OBJECTIVES

Rates of suboptimal bowel preparation up to 30% have been reported. Liberalized precolonoscopy diet, split dose purgative, and the use of MiraLAX-based bowel preparation (MBBP) prior to colonoscopy are recently developed measures to improve bowel preparation quality but little is known about the utilization prevalence of these measures. We examined the patterns of utilization of these newer approaches to improve precolonoscopy bowel preparation quality among American gastroenterologists.

METHODS

Surveys were distributed to a random sample of members of the American College of Gastroenterologists. Participants were queried regarding demographics, practice characteristics, and bowel preparation recommendations including recommendations for liberal dietary restrictions, split dose purgative, and the use of MBBP. Approaches were evaluated individually and in combination.

RESULTS

Of the 999 eligible participants, 288 responded; 15.2% recommended a liberal diet, 60.0% split dose purgative, and 37.4% MBBP. Diet recommendations varied geographically with gastroenterologists in the West more likely to recommend a restrictive diet (odds ratio [OR] 2.98, 95% confidence interval [CI] 1.16-7.67) and physicians in the Northeast more likely to recommend a liberal diet more likely. Older physicians more often recommended split dosing (OR 1.04, 95% CI 1.04-2.97). Use of MBBP was more common in suburban settings (OR 2.14, 95% CI 1.23-3.73). Evidence suggests that physicians in private practice were more likely to prescribe split dosing (p = 0.03) and less often recommended MBBP (p = 0.02). Likelihood of prescribing MBBP increased as weekly volume of colonoscopy increased (p = 0.03).

CONCLUSIONS

To enhance bowel preparation quality American gastroenterologists commonly use purgative split dosing. The use of MBBP is becoming more prevalent while a liberalized diet is infrequently recommended. Utilization of these newer approaches to improve bowel preparation quality varies by physician and practice characteristics. Further evaluation of the patterns of usage of these measures is indicated.

摘要

目的

据报道,肠道准备不充分的发生率高达 30%。最近,为了提高肠道准备质量,人们采用了放宽结肠镜检查前饮食限制、分剂量泻药和使用米拉拉克(MiraLAX)为基础的肠道准备(MBBP)等措施,但对于这些措施的使用情况知之甚少。我们调查了美国胃肠病学家在提高结肠镜检查前肠道准备质量方面使用这些新方法的模式。

方法

向美国胃肠病学会的随机样本成员发放调查问卷。询问参与者的人口统计学、实践特征以及肠道准备建议,包括对宽松饮食限制、分剂量泻药和使用 MBBP 的建议。分别评估了这些方法的应用,并进行了组合评估。

结果

在 999 名合格的参与者中,有 288 名做出了回应;15.2%的人建议进行宽松饮食,60.0%的人建议使用分剂量泻药,37.4%的人建议使用 MBBP。饮食建议因地理位置而异,西部的胃肠病学家更倾向于推荐限制饮食(优势比[OR]2.98,95%置信区间[CI]1.16-7.67),而东北部的医生更倾向于推荐宽松饮食。年长的医生更倾向于推荐分剂量用药(OR 1.04,95% CI 1.04-2.97)。在郊区环境中,MBBP 的使用更为常见(OR 2.14,95% CI 1.23-3.73)。有证据表明,私人执业的医生更有可能开分剂量用药(p=0.03),而不太可能推荐 MBBP(p=0.02)。随着每周结肠镜检查量的增加,开 MBBP 的可能性也随之增加(p=0.03)。

结论

为了提高肠道准备质量,美国胃肠病学家通常使用泻药分剂量用药。MBBP 的使用越来越普遍,而宽松饮食的建议则很少。为提高肠道准备质量而采用的这些新方法的使用情况因医生和实践特征而异。需要进一步评估这些措施的使用模式。